1464 related articles for article (PubMed ID: 18956719)
21. Is video-assisted thoracoscopic surgery a feasible approach for clinical N0 and postoperatively pathological N2 non-small cell lung cancer?
Watanabe A; Mishina T; Ohori S; Koyanagi T; Nakashima S; Mawatari T; Kurimoto Y; Higami T
Eur J Cardiothorac Surg; 2008 May; 33(5):812-8. PubMed ID: 18342533
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
23. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score.
Ishiguro F; Matsuo K; Fukui T; Mori S; Hatooka S; Mitsudomi T
J Thorac Cardiovasc Surg; 2010 Apr; 139(4):1001-6. PubMed ID: 19733863
[TBL] [Abstract][Full Text] [Related]
24. Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.
Fisher ER; Wang J; Bryant J; Fisher B; Mamounas E; Wolmark N
Cancer; 2002 Aug; 95(4):681-95. PubMed ID: 12209710
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients with true pathologic stage I non-small cell lung cancer.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920
[TBL] [Abstract][Full Text] [Related]
26. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
27. Is systemic node dissection for accuracy staging in clinical stage I non-small cell lung cancer worthwhile in the elderly?
Iwasaki A; Hamatake D; Hamanaka W; Hamada T; Shirakusa T; Yamamoto S; Shiraishi T
Thorac Cardiovasc Surg; 2008 Feb; 56(1):37-41. PubMed ID: 18200466
[TBL] [Abstract][Full Text] [Related]
28. Role of skip metastasis to mediastinal lymph nodes in non-small cell lung cancer.
Prenzel KL; Mönig SP; Sinning JM; Baldus SE; Gutschow CA; Grass G; Schneider PM; Hölscher AH
J Surg Oncol; 2003 Apr; 82(4):256-60. PubMed ID: 12672010
[TBL] [Abstract][Full Text] [Related]
29. Skip metastases: analysis of their clinical significance and prognosis in the IIIA stage of non-small cell lung cancer.
Misthos P; Sepsas E; Athanassiadi K; Kakaris S; Skottis I
Eur J Cardiothorac Surg; 2004 Apr; 25(4):502-8. PubMed ID: 15037262
[TBL] [Abstract][Full Text] [Related]
30. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
[TBL] [Abstract][Full Text] [Related]
31. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
[TBL] [Abstract][Full Text] [Related]
32. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
33. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
34. Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W; Yang X; Bai J; Yang J; Manegold C; Wu Y
Eur J Cardiothorac Surg; 2008 Jul; 34(1):187-95. PubMed ID: 18457958
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
Casali C; Stefani A; Natali P; Rossi G; Morandi U
Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
[TBL] [Abstract][Full Text] [Related]
36. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
37. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
38. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
Hsu CP; Hsia JY; Chang GC; Chuang CY; Shai SE; Yang SS; Lee MC; Kwan PC
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
[TBL] [Abstract][Full Text] [Related]
39. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
[TBL] [Abstract][Full Text] [Related]
40. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
